BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $272,936 | -26.2% | 7,232 | -10.8% | 0.02% | -25.0% |
| Q2 2023 | $369,583 | +2.2% | 8,112 | -9.0% | 0.02% | -13.0% |
| Q1 2023 | $361,471 | -22.1% | 8,912 | -2.2% | 0.02% | -25.8% |
| Q4 2022 | $464,289 | -9.0% | 9,109 | -3.7% | 0.03% | -16.2% |
| Q3 2022 | $510,000 | -21.2% | 9,461 | -6.1% | 0.04% | -15.9% |
| Q2 2022 | $647,000 | -49.1% | 10,077 | -38.6% | 0.04% | -42.9% |
| Q1 2022 | $1,271,000 | -9.7% | 16,401 | -0.0% | 0.08% | -6.1% |
| Q4 2021 | $1,408,000 | +8.3% | 16,405 | +1.5% | 0.08% | -2.4% |
| Q3 2021 | $1,300,000 | +1.0% | 16,168 | +1.1% | 0.08% | 0.0% |
| Q2 2021 | $1,287,000 | -5.9% | 15,999 | -1.3% | 0.08% | -12.5% |
| Q1 2021 | $1,368,000 | -39.1% | 16,215 | -42.0% | 0.10% | -44.5% |
| Q4 2020 | $2,245,000 | -0.5% | 27,969 | -0.4% | 0.17% | -13.1% |
| Q3 2020 | $2,257,000 | -5.8% | 28,069 | +0.9% | 0.20% | -11.6% |
| Q2 2020 | $2,396,000 | +6.1% | 27,827 | +0.0% | 0.22% | -11.4% |
| Q1 2020 | $2,259,000 | -4.2% | 27,820 | -1.3% | 0.25% | +21.0% |
| Q4 2019 | $2,357,000 | -7.1% | 28,196 | -2.8% | 0.21% | -14.3% |
| Q3 2019 | $2,538,000 | +53.5% | 29,022 | +43.7% | 0.24% | +45.8% |
| Q2 2019 | $1,653,000 | -0.5% | 20,195 | -1.2% | 0.17% | -3.4% |
| Q1 2019 | $1,662,000 | +23.3% | 20,445 | -0.2% | 0.17% | +10.1% |
| Q4 2018 | $1,348,000 | -14.9% | 20,483 | -1.4% | 0.16% | -13.7% |
| Q3 2018 | $1,584,000 | -49.8% | 20,772 | -51.4% | 0.18% | -9.4% |
| Q2 2018 | $3,157,000 | +1138.0% | 42,779 | +989.6% | 0.20% | +176.7% |
| Q1 2018 | $255,000 | +6.7% | 3,926 | +6.1% | 0.07% | -22.3% |
| Q4 2017 | $239,000 | +0.8% | 3,699 | -2.0% | 0.09% | +1.1% |
| Q3 2017 | $237,000 | +3.9% | 3,773 | 0.0% | 0.09% | -1.1% |
| Q2 2017 | $228,000 | -0.4% | 3,773 | -21.4% | 0.09% | -3.1% |
| Q3 2016 | $229,000 | +2.7% | 4,802 | -2.3% | 0.10% | -1.0% |
| Q2 2016 | $223,000 | -19.8% | 4,917 | -27.5% | 0.10% | -27.4% |
| Q1 2016 | $278,000 | -11.2% | 6,780 | -17.3% | 0.14% | -13.5% |
| Q4 2015 | $313,000 | +18.6% | 8,201 | +1.9% | 0.16% | +4.0% |
| Q3 2015 | $264,000 | -69.0% | 8,045 | -34.0% | 0.15% | -65.0% |
| Q2 2015 | $852,000 | -16.6% | 12,192 | -18.3% | 0.43% | -16.9% |
| Q1 2015 | $1,022,000 | -1.4% | 14,928 | +5.6% | 0.52% | -17.2% |
| Q4 2014 | $1,036,000 | – | 14,140 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |